Compounds that enhance the action of metformin
AssigneeSociete des Produits Nestle S.A.
InventorsDenis Marcel Barron, Nicolas Bonhoure, Yann Ratinaud, Kei Sakamoto, Matthew Sanders
Life of this patent
Estimating the term…
Abstract
The invention relates in general to a medicament comprising Metformin or a salt thereof; and a compound having the general formula (I) or a salt thereof. The invention further relates to a pharmaceutical composition comprising the medicament for use in the prevention or treatment of a metabolic disease or a cardiovascular disease.
Claims19
A medicament comprising
- (i) Metformin;
- and
- (ii) a compound having the general formula (I)
- wherein, in compound (ii), R1, R2, R3, R4, R5, R6, R7, and R8 are each independently H;
- OH;
- OMe;
- O-glycoside;
- a halogen;
- an aldehyde;
- a carboxylic acid;
- a primary, secondary, or tertiary amine;
- a primary or secondary amide;
- a cyano;
- a nitro;
- a sulfonate;
- and a sulfate.
A pharmaceutical composition comprising a medicament comprising
- (i) Metformin;
- and
- (ii) a compound having the general formula (I)
- wherein, in compound (ii), R1, R2, R3, R4, R5, R6, R7, and R8 are each independently H;
- OH;
- OMe;
- O-glycoside;
- a halogen;
- an aldehyde;
- a carboxylic acid;
- a primary, secondary, or tertiary amine;
- a primary or secondary amide;
- a cyano;
- a nitro;
- a sulfonate;
- and a sulfate, in a pharmaceutically acceptable form.
A method of preventing or treating a metabolic disease or a cardiovascular disease comprising the administration of a medicament comprising
- (i) Metformin;
- and
- (ii) a compound having the general formula (I)
- wherein, in compound (ii), R1, R2, R3, R4, R5, R6, R7, and R8 are each independently H;
- OH;
- OMe;
- O-glycoside;
- a halogen;
- an aldehyde;
- a carboxylic acid;
- a primary, secondary, or tertiary amine;
- a primary or secondary amide;
- a cyano;
- a nitro;
- a sulfonate;
- and a sulfate to a subject in need thereof.
Dependencies are inferred from the claim text.